BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34004061)

  • 1. Identification of immune-activating metabolite for enhancing T cell therapy of cancer.
    Cong B; Cui Z; Cao X
    Cancer Commun (Lond); 2021 Jul; 41(7):535-537. PubMed ID: 34004061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asparagine enhances LCK signalling to potentiate CD8
    Wu J; Li G; Li L; Li D; Dong Z; Jiang P
    Nat Cell Biol; 2021 Jan; 23(1):75-86. PubMed ID: 33420490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
    Nyakeriga AM; Garg H; Joshi A
    Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Stimulatory pMHC Enhance CD8 T Cell Effector Functions by Recruiting Coreceptor-Bound Lck.
    Zhao X; Wu LZ; Ng EKY; Leow KWS; Wei Q; Gascoigne NRJ; Brzostek J
    Front Immunol; 2021; 12():721722. PubMed ID: 34707605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.
    Moogk D; Zhong S; Yu Z; Liadi I; Rittase W; Fang V; Dougherty J; Perez-Garcia A; Osman I; Zhu C; Varadarajan N; Restifo NP; Frey AB; Krogsgaard M
    J Immunol; 2016 Jul; 197(2):644-54. PubMed ID: 27271569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56
    Kästle M; Merten C; Hartig R; Kaehne T; Liaunardy-Jopeace A; Woessner NM; Schamel WW; James J; Minguet S; Simeoni L; Schraven B
    Cell Commun Signal; 2020 Nov; 18(1):183. PubMed ID: 33225946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development.
    Irie HY; Mong MS; Itano A; Crooks ME; Littman DR; Burakoff SJ; Robey E
    J Immunol; 1998 Jul; 161(1):183-91. PubMed ID: 9647223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Characterization of the Amphioxus Lck and Its Associated Tyrosine Phosphorylation-Dependent Inhibitory LRR Receptor.
    Zhou J; Xiao Z; Zhan Y; Qu X; Mou S; Deng C; Zhang T; Lan X; Huang S; Li Y
    Front Immunol; 2021; 12():656366. PubMed ID: 34149695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encoding optical control in LCK kinase to quantitatively investigate its activity in live cells.
    Liaunardy-Jopeace A; Murton BL; Mahesh M; Chin JW; James JR
    Nat Struct Mol Biol; 2017 Dec; 24(12):1155-1163. PubMed ID: 29083415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.
    Monu N; Frey AB
    Cancer Res; 2007 Dec; 67(23):11447-54. PubMed ID: 18056473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia.
    Hubert P; Bergeron F; Ferreira V; Seligmann M; Oksenhendler E; Debre P; Autran B
    Int Immunol; 2000 Apr; 12(4):449-57. PubMed ID: 10744646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of protein kinase Ctheta function during T cell activation by Lck-mediated tyrosine phosphorylation.
    Liu Y; Witte S; Liu YC; Doyle M; Elly C; Altman A
    J Biol Chem; 2000 Feb; 275(5):3603-9. PubMed ID: 10652356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative Regulation of Zap70 by Lck Forms the Mechanistic Basis of Differential Expression in CD4 and CD8 T Cells.
    Damen H; Tebid C; Viens M; Roy DC; Dave VP
    Front Immunol; 2022; 13():935367. PubMed ID: 35860252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of the Coreceptor-LCK Interactions during T Cell Development Shape the Self-Reactivity of Peripheral CD4 and CD8 T Cells.
    Horkova V; Drobek A; Mueller D; Gubser C; Niederlova V; Wyss L; King CG; Zehn D; Stepanek O
    Cell Rep; 2020 Feb; 30(5):1504-1514.e7. PubMed ID: 32023465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
    Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
    Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of competing mechanisms on Lck regulation.
    Bozso SJ; Kang JJH; Nagendran J
    Immunol Res; 2020 Oct; 68(5):289-295. PubMed ID: 32794043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells.
    Campbell NA; Kim HS; Blumberg RS; Mayer L
    J Biol Chem; 1999 Sep; 274(37):26259-65. PubMed ID: 10473580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes.
    Arcaro A; Grégoire C; Bakker TR; Baldi L; Jordan M; Goffin L; Boucheron N; Wurm F; van der Merwe PA; Malissen B; Luescher IF
    J Exp Med; 2001 Nov; 194(10):1485-95. PubMed ID: 11714755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the Discovery of the CD4/CD8-p56
    Rudd CE
    Front Cell Dev Biol; 2021; 9():626095. PubMed ID: 33791292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes.
    Kabouridis PS; Magee AI; Ley SC
    EMBO J; 1997 Aug; 16(16):4983-98. PubMed ID: 9305640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.